Home/Filings/4/0001209191-23-059919
4//SEC Filing

TAYMANS JILL M 4

Accession 0001209191-23-059919

CIK 0000862692other

Filed

Dec 27, 7:00 PM ET

Accepted

Dec 28, 5:00 PM ET

Size

9.8 KB

Accession

0001209191-23-059919

Insider Transaction Report

Form 4
Period: 2023-12-22
TAYMANS JILL M
VP Finance, CFO
Transactions
  • Award

    Stock Option

    2023-12-22$5.88/sh+10,000$58,80010,000 total
    Exercise: $5.88From: 2023-12-22Exp: 2028-12-22Common Stock (10,000 underlying)
Holdings
  • Stock Option

    Exercise: $3.10From: 2019-06-02Exp: 2016-06-02Common Stock (7,500 underlying)
    7,500
  • Stock Option

    Exercise: $8.00From: 2021-09-22Exp: 2027-09-22Common Stock (7,000 underlying)
    7,000
  • Stock Option

    Exercise: $4.62From: 2023-01-13Exp: 2028-01-13Common Stock (20,000 underlying)
    20,000
  • Common Stock

    45,396
Footnotes (3)
  • [F1]Stock options vest at a rate of 1/5 annually commencing on September 23, 2021.
  • [F2]Stock options fully vest upon issuance.
  • [F3]Stock options vest 1/3 upon issuance, 1/3 on December 22, 2024 and 1/3 on December 22, 2025.

Issuer

CRYO CELL INTERNATIONAL INC

CIK 0000862692

Entity typeother

Related Parties

1
  • filerCIK 0001261283

Filing Metadata

Form type
4
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 5:00 PM ET
Size
9.8 KB